Medikamentöse Behandlung der chronisch verlaufenden Glomerulonephritiden: Contra View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1985-09

AUTHORS

K. Andrassy, R. Waldherr, E. Ritz

ABSTRACT

It is controversial whether the pathomechanisms involved in chronic idiopathic glomerulonephritis are susceptible to therapeutic intervention. Etiological therapy, i.e. elimintion of the responsible antigen, is possible only in exceptional cases, e.g. tropical diseases, infected ventriculoatrial shunt etc. Antiinflammatory therapy directed against pathomechanisms initiating or maintaining glomerular inflammation has an uncertain theoretical foundation because of lack of knowledge relating to the exact steps mediating tissue injury. Recent studies suggest keyroles for terminal components of complement system, products of lipoxygenase pathway of arachidonic acid and oxygen radicals — all of which are not readily influenced by available therapeutic modulaties. Finally, progression of glomerular inflammation to renal failure is usually not the cause of cumulative acute inflammatory glomerular lesions but rather the consequence of progressive sclerosis of glomeruli, arterioles and interstitium. As examples of controlled intervention trials, studies on extramembranous and membranoproliferative glomerulonephritis are discussed. The studies show limited and not always statistically significant influence on renal function, however, at the expense of considerable side effects. It is concluded that it is highly questionable whether inflammatory pathomechanisms are influenced by currently available drugs. However, therapeutic nihilism is not appropriate given modalities to influence mechanisms of nonspecific damage, e.g. by antihypertensive medication or dietary intervention. More... »

PAGES

978-987

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf01738153

DOI

http://dx.doi.org/10.1007/bf01738153

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1036985622

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/3903341


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/03", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Chemical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0304", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medicinal and Biomolecular Chemistry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Azathioprine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chlorambucil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chronic Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clinical Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclophosphamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glomerulonephritis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney Function Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney Glomerulus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lupus Erythematosus, Systemic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Methylprednisolone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Platelet Aggregation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prednisone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Medinische Klinik der Universit\u00e4t Heidelberg, Germany", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medinische Klinik der Universit\u00e4t Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Andrassy", 
        "givenName": "K.", 
        "id": "sg:person.0645052243.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645052243.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Pathologisches Institut der Universit\u00e4t Heidelberg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.5252.0", 
          "name": [
            "Pathologisches Institut der Universit\u00e4t Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Waldherr", 
        "givenName": "R.", 
        "id": "sg:person.01041273513.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01041273513.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medinische Klinik der Universit\u00e4t Heidelberg, Germany", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medinische Klinik der Universit\u00e4t Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ritz", 
        "givenName": "E.", 
        "id": "sg:person.01152777576.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152777576.10"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf01715839", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003422685", 
          "https://doi.org/10.1007/bf01715839"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-4612-5284-9_129", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1089508457", 
          "https://doi.org/10.1007/978-1-4612-5284-9_129"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-4612-5284-9_55", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1089508522", 
          "https://doi.org/10.1007/978-1-4612-5284-9_55"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01476873", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040334033", 
          "https://doi.org/10.1007/bf01476873"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1985-09", 
    "datePublishedReg": "1985-09-01", 
    "description": "It is controversial whether the pathomechanisms involved in chronic idiopathic glomerulonephritis are susceptible to therapeutic intervention. Etiological therapy, i.e. elimintion of the responsible antigen, is possible only in exceptional cases, e.g. tropical diseases, infected ventriculoatrial shunt etc. Antiinflammatory therapy directed against pathomechanisms initiating or maintaining glomerular inflammation has an uncertain theoretical foundation because of lack of knowledge relating to the exact steps mediating tissue injury. Recent studies suggest keyroles for terminal components of complement system, products of lipoxygenase pathway of arachidonic acid and oxygen radicals \u2014 all of which are not readily influenced by available therapeutic modulaties. Finally, progression of glomerular inflammation to renal failure is usually not the cause of cumulative acute inflammatory glomerular lesions but rather the consequence of progressive sclerosis of glomeruli, arterioles and interstitium. As examples of controlled intervention trials, studies on extramembranous and membranoproliferative glomerulonephritis are discussed. The studies show limited and not always statistically significant influence on renal function, however, at the expense of considerable side effects. It is concluded that it is highly questionable whether inflammatory pathomechanisms are influenced by currently available drugs. However, therapeutic nihilism is not appropriate given modalities to influence mechanisms of nonspecific damage, e.g. by antihypertensive medication or dietary intervention.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/bf01738153", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1057918", 
        "issn": [
          "0946-2716", 
          "1432-1440"
        ], 
        "name": "Journal of Molecular Medicine", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "18", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "63"
      }
    ], 
    "keywords": [
      "glomerular inflammation", 
      "inflammatory glomerular lesions", 
      "considerable side effects", 
      "inflammatory pathomechanism", 
      "antihypertensive medications", 
      "antiinflammatory therapy", 
      "renal failure", 
      "progressive sclerosis", 
      "renal function", 
      "responsible antigen", 
      "ventriculoatrial shunt", 
      "membranoproliferative glomerulonephritis", 
      "dietary intervention", 
      "idiopathic glomerulonephritis", 
      "glomerular lesions", 
      "intervention trials", 
      "therapeutic nihilism", 
      "tissue injury", 
      "etiological therapy", 
      "side effects", 
      "available drugs", 
      "therapeutic interventions", 
      "tropical diseases", 
      "complement system", 
      "arachidonic acid", 
      "lipoxygenase pathway", 
      "oxygen radicals", 
      "nonspecific damage", 
      "glomerulonephritis", 
      "inflammation", 
      "therapy", 
      "pathomechanism", 
      "intervention", 
      "lack of knowledge", 
      "Recent studies", 
      "terminal components", 
      "medications", 
      "sclerosis", 
      "arterioles", 
      "injury", 
      "lesions", 
      "glomeruli", 
      "shunt", 
      "antigen", 
      "disease", 
      "interstitium", 
      "progression", 
      "trials", 
      "Behandlung", 
      "study", 
      "drugs", 
      "exceptional cases", 
      "modalities", 
      "cause", 
      "failure", 
      "pathway", 
      "damage", 
      "cases", 
      "contra", 
      "lack", 
      "effect", 
      "acid", 
      "mechanism", 
      "exact steps", 
      "function", 
      "keyrole", 
      "consequences", 
      "knowledge", 
      "significant influence", 
      "radicals", 
      "components", 
      "expense", 
      "nihilism", 
      "influence", 
      "products", 
      "system", 
      "step", 
      "foundation", 
      "example", 
      "theoretical foundation"
    ], 
    "name": "Medikament\u00f6se Behandlung der chronisch verlaufenden Glomerulonephritiden: Contra", 
    "pagination": "978-987", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1036985622"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf01738153"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "3903341"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf01738153", 
      "https://app.dimensions.ai/details/publication/pub.1036985622"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T20:46", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_202.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/bf01738153"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf01738153'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf01738153'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf01738153'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf01738153'


 

This table displays all metadata directly associated to this object as RDF triples.

234 TRIPLES      21 PREDICATES      125 URIs      113 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf01738153 schema:about N22041a61802a423eb357d442fabace19
2 N364e6e6794f3486ba9dd06ccd680f920
3 N5718e08007fa44fabfa58ac70ea7fa3f
4 N58cdd42305c446098897bdfa0898a1a3
5 N5a6dc1c59a3b49e483c163277b1f3a80
6 N6f636a49c2e0425d9baf130278d2c5bb
7 N790931e0ad0a454f9470ca88f4e1bdf9
8 N7f8203cc93b2400b8b8c146798308d70
9 Nb83ab8f87bd3499381068daa5ff56bcf
10 Nca23f732f4b1453296c5b2d8cb14f4a7
11 Ncd8b2ddd8ccb4e18ab1011ab4dcf245a
12 Ndc454c137f274e4aa25865b1b02edeb8
13 Ne3079ad27a404d69bec22d12bfb0affc
14 Nfa47902f8aaf4c18b77027c064757875
15 Nfac8ba27616b4a82a746d5cb332ecf45
16 anzsrc-for:03
17 anzsrc-for:0304
18 schema:author N416d732266604ecd8f3b78819a195bc1
19 schema:citation sg:pub.10.1007/978-1-4612-5284-9_129
20 sg:pub.10.1007/978-1-4612-5284-9_55
21 sg:pub.10.1007/bf01476873
22 sg:pub.10.1007/bf01715839
23 schema:datePublished 1985-09
24 schema:datePublishedReg 1985-09-01
25 schema:description It is controversial whether the pathomechanisms involved in chronic idiopathic glomerulonephritis are susceptible to therapeutic intervention. Etiological therapy, i.e. elimintion of the responsible antigen, is possible only in exceptional cases, e.g. tropical diseases, infected ventriculoatrial shunt etc. Antiinflammatory therapy directed against pathomechanisms initiating or maintaining glomerular inflammation has an uncertain theoretical foundation because of lack of knowledge relating to the exact steps mediating tissue injury. Recent studies suggest keyroles for terminal components of complement system, products of lipoxygenase pathway of arachidonic acid and oxygen radicals — all of which are not readily influenced by available therapeutic modulaties. Finally, progression of glomerular inflammation to renal failure is usually not the cause of cumulative acute inflammatory glomerular lesions but rather the consequence of progressive sclerosis of glomeruli, arterioles and interstitium. As examples of controlled intervention trials, studies on extramembranous and membranoproliferative glomerulonephritis are discussed. The studies show limited and not always statistically significant influence on renal function, however, at the expense of considerable side effects. It is concluded that it is highly questionable whether inflammatory pathomechanisms are influenced by currently available drugs. However, therapeutic nihilism is not appropriate given modalities to influence mechanisms of nonspecific damage, e.g. by antihypertensive medication or dietary intervention.
26 schema:genre article
27 schema:isAccessibleForFree false
28 schema:isPartOf N5413327a58f94e81985b99f4611c8b5b
29 Nc20a319eb75e4ef490a5e24542245d98
30 sg:journal.1057918
31 schema:keywords Behandlung
32 Recent studies
33 acid
34 antigen
35 antihypertensive medications
36 antiinflammatory therapy
37 arachidonic acid
38 arterioles
39 available drugs
40 cases
41 cause
42 complement system
43 components
44 consequences
45 considerable side effects
46 contra
47 damage
48 dietary intervention
49 disease
50 drugs
51 effect
52 etiological therapy
53 exact steps
54 example
55 exceptional cases
56 expense
57 failure
58 foundation
59 function
60 glomerular inflammation
61 glomerular lesions
62 glomeruli
63 glomerulonephritis
64 idiopathic glomerulonephritis
65 inflammation
66 inflammatory glomerular lesions
67 inflammatory pathomechanism
68 influence
69 injury
70 interstitium
71 intervention
72 intervention trials
73 keyrole
74 knowledge
75 lack
76 lack of knowledge
77 lesions
78 lipoxygenase pathway
79 mechanism
80 medications
81 membranoproliferative glomerulonephritis
82 modalities
83 nihilism
84 nonspecific damage
85 oxygen radicals
86 pathomechanism
87 pathway
88 products
89 progression
90 progressive sclerosis
91 radicals
92 renal failure
93 renal function
94 responsible antigen
95 sclerosis
96 shunt
97 side effects
98 significant influence
99 step
100 study
101 system
102 terminal components
103 theoretical foundation
104 therapeutic interventions
105 therapeutic nihilism
106 therapy
107 tissue injury
108 trials
109 tropical diseases
110 ventriculoatrial shunt
111 schema:name Medikamentöse Behandlung der chronisch verlaufenden Glomerulonephritiden: Contra
112 schema:pagination 978-987
113 schema:productId N17a31b20e1dd4b329e8032b37a187422
114 N4fdc6b374a974474b931efd320d023bf
115 Necb15ed5f5e044879a61970e4610d323
116 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036985622
117 https://doi.org/10.1007/bf01738153
118 schema:sdDatePublished 2022-11-24T20:46
119 schema:sdLicense https://scigraph.springernature.com/explorer/license/
120 schema:sdPublisher Nf6a8e56bac8b414094187445e131341a
121 schema:url https://doi.org/10.1007/bf01738153
122 sgo:license sg:explorer/license/
123 sgo:sdDataset articles
124 rdf:type schema:ScholarlyArticle
125 N030252742b334eef9f97948e4c8e2676 rdf:first sg:person.01041273513.06
126 rdf:rest Nf90a3c8750c84d9c8aa312ed3b8de0b1
127 N17a31b20e1dd4b329e8032b37a187422 schema:name doi
128 schema:value 10.1007/bf01738153
129 rdf:type schema:PropertyValue
130 N22041a61802a423eb357d442fabace19 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Clinical Trials as Topic
132 rdf:type schema:DefinedTerm
133 N364e6e6794f3486ba9dd06ccd680f920 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Prednisone
135 rdf:type schema:DefinedTerm
136 N416d732266604ecd8f3b78819a195bc1 rdf:first sg:person.0645052243.29
137 rdf:rest N030252742b334eef9f97948e4c8e2676
138 N4fdc6b374a974474b931efd320d023bf schema:name dimensions_id
139 schema:value pub.1036985622
140 rdf:type schema:PropertyValue
141 N5413327a58f94e81985b99f4611c8b5b schema:issueNumber 18
142 rdf:type schema:PublicationIssue
143 N5718e08007fa44fabfa58ac70ea7fa3f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Chlorambucil
145 rdf:type schema:DefinedTerm
146 N58cdd42305c446098897bdfa0898a1a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Drug Therapy, Combination
148 rdf:type schema:DefinedTerm
149 N5a6dc1c59a3b49e483c163277b1f3a80 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Cyclophosphamide
151 rdf:type schema:DefinedTerm
152 N6f636a49c2e0425d9baf130278d2c5bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Azathioprine
154 rdf:type schema:DefinedTerm
155 N790931e0ad0a454f9470ca88f4e1bdf9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Chronic Disease
157 rdf:type schema:DefinedTerm
158 N7f8203cc93b2400b8b8c146798308d70 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Lupus Erythematosus, Systemic
160 rdf:type schema:DefinedTerm
161 Nb83ab8f87bd3499381068daa5ff56bcf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Kidney Glomerulus
163 rdf:type schema:DefinedTerm
164 Nc20a319eb75e4ef490a5e24542245d98 schema:volumeNumber 63
165 rdf:type schema:PublicationVolume
166 Nca23f732f4b1453296c5b2d8cb14f4a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Prognosis
168 rdf:type schema:DefinedTerm
169 Ncd8b2ddd8ccb4e18ab1011ab4dcf245a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Methylprednisolone
171 rdf:type schema:DefinedTerm
172 Ndc454c137f274e4aa25865b1b02edeb8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Kidney Function Tests
174 rdf:type schema:DefinedTerm
175 Ne3079ad27a404d69bec22d12bfb0affc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Platelet Aggregation
177 rdf:type schema:DefinedTerm
178 Necb15ed5f5e044879a61970e4610d323 schema:name pubmed_id
179 schema:value 3903341
180 rdf:type schema:PropertyValue
181 Nf6a8e56bac8b414094187445e131341a schema:name Springer Nature - SN SciGraph project
182 rdf:type schema:Organization
183 Nf90a3c8750c84d9c8aa312ed3b8de0b1 rdf:first sg:person.01152777576.10
184 rdf:rest rdf:nil
185 Nfa47902f8aaf4c18b77027c064757875 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Humans
187 rdf:type schema:DefinedTerm
188 Nfac8ba27616b4a82a746d5cb332ecf45 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Glomerulonephritis
190 rdf:type schema:DefinedTerm
191 anzsrc-for:03 schema:inDefinedTermSet anzsrc-for:
192 schema:name Chemical Sciences
193 rdf:type schema:DefinedTerm
194 anzsrc-for:0304 schema:inDefinedTermSet anzsrc-for:
195 schema:name Medicinal and Biomolecular Chemistry
196 rdf:type schema:DefinedTerm
197 sg:journal.1057918 schema:issn 0946-2716
198 1432-1440
199 schema:name Journal of Molecular Medicine
200 schema:publisher Springer Nature
201 rdf:type schema:Periodical
202 sg:person.01041273513.06 schema:affiliation grid-institutes:grid.5252.0
203 schema:familyName Waldherr
204 schema:givenName R.
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01041273513.06
206 rdf:type schema:Person
207 sg:person.01152777576.10 schema:affiliation grid-institutes:None
208 schema:familyName Ritz
209 schema:givenName E.
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152777576.10
211 rdf:type schema:Person
212 sg:person.0645052243.29 schema:affiliation grid-institutes:None
213 schema:familyName Andrassy
214 schema:givenName K.
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645052243.29
216 rdf:type schema:Person
217 sg:pub.10.1007/978-1-4612-5284-9_129 schema:sameAs https://app.dimensions.ai/details/publication/pub.1089508457
218 https://doi.org/10.1007/978-1-4612-5284-9_129
219 rdf:type schema:CreativeWork
220 sg:pub.10.1007/978-1-4612-5284-9_55 schema:sameAs https://app.dimensions.ai/details/publication/pub.1089508522
221 https://doi.org/10.1007/978-1-4612-5284-9_55
222 rdf:type schema:CreativeWork
223 sg:pub.10.1007/bf01476873 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040334033
224 https://doi.org/10.1007/bf01476873
225 rdf:type schema:CreativeWork
226 sg:pub.10.1007/bf01715839 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003422685
227 https://doi.org/10.1007/bf01715839
228 rdf:type schema:CreativeWork
229 grid-institutes:None schema:alternateName Medinische Klinik der Universität Heidelberg, Germany
230 schema:name Medinische Klinik der Universität Heidelberg, Germany
231 rdf:type schema:Organization
232 grid-institutes:grid.5252.0 schema:alternateName Pathologisches Institut der Universität Heidelberg, Germany
233 schema:name Pathologisches Institut der Universität Heidelberg, Germany
234 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...